SS Gottlieb, RJ McCarter, RA Vogel - New England Journal of …, 1998 - content.nejm.org ABSTRACT Background Long-term administration of beta- adrenergic blockers to patients after
myocardial in- farction improves survival. However, physicians are reluctant to administer
beta-blockers to many pa- tients, ... Cited by 771 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org ML Kukin, J Kalman, RH Charney, DK Levy, C … - Circulation, 1999 - Am Heart Assoc Methods and Results—Sixty-seven patients with symptomatic stable heart failure were randomly
assigned to receive either carvedilol or metoprolol in addition to standard therapy for CHF.
Measured variables included ... Cited by 272 - Related articles - BL Direct - All 5 versions
- ►labiomed.org [PDF] CW Yancy, MB Fowler, WS Colucci, EM … - New England Journal …, 2001 - content.nejm.org ABSTRACT Background The benefits of angiotensin-convert- ing–enzyme inhibitors and beta-blockers
may be smaller in black patients than in patients of other rac- es, but it is unknown whether race
influences the re- sponse to ... Cited by 240 - Related articles - BL Direct - All 12 versions
GL Bakris, V Fonseca, RE Katholi, JB McGill, FH … - Jama, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web standards. Find out
more about why this message is appearing and what you can do to make your experience on this site
better. ... Add to CiteULike Add ... Cited by 234 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org DSH Bell - Diabetes Care, 2003 - Am Diabetes Assoc There is a high frequency of heart failure (HF) accompanied by an increased mortality risk for
patients with diabetes. The poor prognosis of these patients has been explained by an underlying
diabetic cardiomyopathy exacerbated ... Cited by 171 - Related articles - BL Direct - All 8 versions
[CITATION] Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes …
G Feuerstein, TL Yue, X Ma, RR Ruffolo - Progress in cardiovascular diseases, 1998 - Elsevier Carvedilol is a novel cardiovascular drug of proven efficacy in the treatment of hypertension,
angina, and heart failure. Several mechanisms may account for the beneficial effects of carvedilol
in patients with heart failure. As ... Cited by 112 - Related articles - BL Direct - All 6 versions
- ►endojournals.org R Muniyappa, M Montagnani, KK Koh, MJ Quon - Endocrine reviews, 2007 - Endocrine Soc Insulin has important vascular actions to stimulate production of nitric oxide from endothelium.
This leads to capillary recruitment, vasodilation, increased blood flow, and subsequent augmentation
of glucose disposal in classical ... Cited by 101 - Related articles - BL Direct - All 5 versions
B Luna, MN Feinglos - JAMA, 2001 - Am Med Assoc Thiazide diuretic–induced hyperglycemia occurs primarily through the reduction in total body
potassium and the subsequent decreased insulin secretion. This effect is largely dose-dependent and
reversed by potassium replacement ... Cited by 74 - Related articles - BL Direct - All 4 versions
M Packer - Journal of cardiac failure, 2003 - Elsevier Experimental and clinical studies indicate that carvedilol exerts multiple antiadrenergic effects in
addition to β 1 -receptor blockade, but the prognostic importance of these actions has long been
debated. This controversy has now ... Cited by 73 - Related articles - All 10 versions
